New medical-scientific article on A/H1N1 epidemic

Clinical features of the first phase

A special issue of Deutsches -rzteblatt International contains the first scientific presentation of clinical experience with the novel influenza A virus (H1N1/09) in the German-speaking countries since the start of the pandemic. Ralf Winzer and his coauthors from the D-sseldorf University Hospital retrospectively evaluated data from a large clinical cohort of infected persons in Germany (Dtsch Arztebl Int 2009; 106[47]: 770-6). Their medical-scientific article is accompanied by an editorial by the clinical microbiologist Georg Peters of the University of M-nster (Dtsch Arztebl Int 2009; 106[769]).

The results of the study by Winzer et al. corroborate the initial research findings on the A/H1N1 epidemic. In the initial phase of the pandemic, the disease tended to take a mild course and most infections in the German population were acquired outside the country. Later on, as Peters explains, more severe cases were reported in Germany as well, and most infections with the novel influenza A (H1N1) virus are now being acquired within the country.

In a further, thematically related article, Rafael Mikolajczyk and coauthors explain the principles underlying model calculations of the course of an epidemic. Their article does not contain a direct extrapolation of current data about the novel influenza A virus (H1N1/09), yet it describes the theoretical foundation of calculations that apply to all epidemics, including influenza epidemics.

Source: Deutsches Aerzteblatt International

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Elevated antibody responses to Epstein-Barr virus linked to increased risk of multiple sclerosis